ConductScience.org, home

Paper23816319

Evaluation of analgesic, antioxidant, cytotoxic and metabolic effects of pregabalin for the use in neuropathic pain.

Sałat K and 3 others. Neurol Res, 2013. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Evaluation of analgesic, antioxidant, cytotoxic and metabolic effects of pregabalin for the use in neuropathic pain. Papers, record 23816319. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23816319

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evaluation of analgesic, antioxidant, cytotoxic and metabolic effects of pregabalin for the use in neuropathic pain.
PubMed
Journal
Neurol Res
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
0.86
iCite
Revised in PubMed
2022-03-30
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sałat KKinga
2Librowski TTadeusz
3Nawiesniak BBarbara
4Gluch-Lutwin MMonika

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AnalgesicsMajor topic
AntioxidantsMajor topic
Diabetic NeuropathiesMajor topic
NeuralgiaMajor topic
gamma-Aminobutyric AcidMajor topic
3T3-L1 Cells
Animals
Cell Death
Diabetes Mellitus, Experimental
Glucose
Hep G2 Cells
Humans
Hyperalgesia
Lipid Metabolism
Male
Mice
Motor Skills
Pain Threshold
Pregabalin
Rosiglitazone
Terfenadine
Thiazolidinediones

Source PubMed

Download CSV of topics

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
41091232Dosimetric parameters and clinical outcomes of photobiomodulation in diabetic neuropathy: a concise review.Lasers Med Sci2025https://conductscience.org/library/papers/41091232PubMed
40748554Investigation of the effects of gabapentin on high glucose-induced neurotoxicity and genotoxicity in an in vitro model of diabetic neuropathy and in silico molecular docking analysis.Mol Biol Rep2025https://conductscience.org/library/papers/40748554PubMed
39431036Evaluation of the teratogenic effects of pregabalin usage during pregnancy: A multicenter case-control study.North Clin Istanb2024https://conductscience.org/library/papers/39431036PubMed
39166118Daidzein ameliorates peripheral neuropathy in Sprague Dawley rats.Front Pharmacol2024https://conductscience.org/library/papers/39166118PubMed
37314657Solasodine Containing Solanum torvum L. Fruit Extract Prevents Chronic Constriction Injury-Induced Neuropathic Pain in Rats: In Silico and In Vivo Evidence of TRPV1 Receptor and Cytokine Inhibition.Mol Neurobiol2023https://conductscience.org/library/papers/37314657PubMed
36826317Preparation, Characterization, and Evaluation of Cytotoxicity of Fast Dissolving Hydrogel Based Oral Thin Films Containing Pregabalin and Methylcobalamin.Gels2023https://conductscience.org/library/papers/36826317PubMed
35269474The Effects of Prenatal Exposure to Pregabalin on the Development of Ventral Midbrain Dopaminergic Neurons.Cells2022https://conductscience.org/library/papers/35269474PubMed
35191013Maternal exposure to the environmental pollutant "BDE-47" impairs the postnatal development of rat cerebellar cortex by modulating neuronal proliferation, synaptogenesis, NGF and BDNF pathways.Histol Histopathol2022https://conductscience.org/library/papers/35191013PubMed
34966012Pharmacological interactions between intrathecal pregabalin plus tianeptine or clopidogrel in a rat model of neuropathic pain.Korean J Pain2022https://conductscience.org/library/papers/34966012PubMed
33215875SMTP-44D improves diabetic neuropathy symptoms in mice through its antioxidant and anti-inflammatory activities.Pharmacol Res Perspect2020https://conductscience.org/library/papers/33215875PubMed
30393488Evaluation of the effects of pregabalin on chondrocyte proliferation and CHAD, HIF-1α, and COL2A1 gene expression.Arch Med Sci2018https://conductscience.org/library/papers/30393488PubMed
30112057Pregabalin treatment for neuropathic pain may damage intervertebral disc tissue.Exp Ther Med2018https://conductscience.org/library/papers/30112057PubMed
29950890Short-term incubation of gabapentin or pregabalin does not affect chemically induced injury in neuronal cell models in vitro.J Pain Res2018https://conductscience.org/library/papers/29950890PubMed
28332005Levetiracetam synergizes with gabapentin, pregabalin, duloxetine and selected antioxidants in a mouse diabetic painful neuropathy model.Psychopharmacology (Berl)2017https://conductscience.org/library/papers/28332005PubMed
26984821Effect of pregabalin on contextual memory deficits and inflammatory state-related protein expression in streptozotocin-induced diabetic mice.Naunyn Schmiedebergs Arch Pharmacol2016https://conductscience.org/library/papers/26984821PubMed
24851240The antiallodynic action of pregabalin may depend on the suppression of spinal neuronal hyperexcitability in rats with spared nerve injury.Pain Res Manag2014https://conductscience.org/library/papers/24851240PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23816319

GET https://conductscience.org/api/papers/v1/23816319/authors